Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancyK. Kaji, Kazuhiko Takehara, Munenari Itoh et al.|Lara D. Veeken|2006Cited by 307
Autoantibodies to RuvBL1 and RuvBL2: A Novel Systemic Sclerosis–Related Antibody Associated With Diffuse Cutaneous and Skeletal Muscle InvolvementK. Kaji, Masataka Kuwana, Noreen Fertig et al.|Arthritis Care & Research|2013Cited by 117
The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosisYasuhito Hamaguchi, Shinichi Sato, Minoru Hasegawa et al.|British Journal of Dermatology|2008Cited by 115
Association of distinct clinical subsets with myositis‐specific autoantibodies towards anti‐155/140‐kDa polypeptides, anti‐140‐kDa polypeptides, and anti‐aminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a single‐centre, cross‐sectional studyKeita Fujikawa, Katsumi Eguchi, Atsushi Kawakami et al.|Scandinavian Journal of Rheumatology|2009Cited by 88
Reduced red blood cell velocity in nail-fold capillaries as a sensitive and specific indicator of microcirculation injury in systemic sclerosisNaoki Mugii, K. Takehara, Minoru Hasegawa et al.|Lara D. Veeken|2009Cited by 60